Nov 22, 2021
Lytix Biopharma will release its third quarter 2021 results on Thursday, 25 November

The results will be published at 7:00 am CEST and followed by a live webinar with CEO Øystein Rekdal, CDO Graeme Currie and CFO Gjest Andreas Breistein at 2:30 pm CEST. 

The presentation and subsequent Q&A session will be held in English and may be viewed live at

A recording of the presentation will be made available on after the presentation.